COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Formycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®)
Formycon announces commercial launch of FYB201 (Ranibizumab) in Canada and Switzerland, expanding availability in 17 countries. Biosimilar offers cost-effective treatment for retinal diseases -
-
COMMUNIQUÉ DE PRESSE
tonies achieves EBITDA profitability and delivers substantial revenue growth of 40% YoY – positive free cash flow expected for 2024
tonies SE achieves EBITDA profitability with 40% YoY revenue growth in FY 2023, plans positive free cash flow for 2024. International expansion drives success -
-
-
COMMUNIQUÉ DE PRESSE
Helvetia reports a robust result for 2023, increases its dividend and successfully implements its strategy
Helvetia's 2023 annual results show robust performance, increased dividend, and strategic implementation, marked by high claims due to natural catastrophes and growth in business volume -
-
-
